Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy

This publication has 15 references indexed in Scilit:

• Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
  Circulation, 1986
• Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
  Circulation, 1986
• Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease
  The American Journal of Cardiology, 1985
• Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
  Circulation, 1984
• Drugs Five Years Later
  Annals of Internal Medicine, 1983
• Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure
  New England Journal of Medicine, 1983
• The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
  American Heart Journal, 1983
• Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
  Circulation, 1983
• Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol
  New England Journal of Medicine, 1981
• Tolerance to dobutamine after a 72 hour continuous infusion
  The American Journal of Medicine, 1980